Annovis Bio, Inc.

NYSE:ANVS

8.47 (USD) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Assets:
Current Assets:
Cash & Cash Equivalents 5.75528.37845.6868.0750.0020.0350.347
Short Term Investments 0000000
Cash and Short Term Investments 5.75528.37845.6868.0750.0020.0350.347
Net Receivables 00000.73500
Inventory 0000-745.64300
Other Current Assets 4.4547,644.376315.46444.676745.6540.0160.01
Total Current Assets 10.20836.02246.0018.1190.7480.0510.358
Non-Current Assets:
Property, Plant & Equipment, Net 0000000
Goodwill 0000000
Intangible Assets 0000000
Goodwill and Intangible Assets 0000000
Long Term Investments 0000000
Tax Assets 0000000
Other Non-Current Assets 00000.3700
Total Non-Current Assets 00000.3700
Total Assets 10.20836.02246.0018.1191.1170.0510.358
Liabilities & Equity:
Current Liabilities:
Account Payables 1.2933.9610.6880.3421.2340.0680.071
Short Term Debt 0000000
Tax Payables 0000000
Deferred Revenue 0000000
Other Current Liabilities 2.9863.7370.8180.2370.7770.50.419
Total Current Liabilities 4.2797.6991.5070.5782.0110.5680.49
Non-Current Liabilities:
Long Term Debt 00000.500
Deferred Revenue Non-Current 0000000
Deferred Tax Liabilities Non-Current 0000000
Other Non-Current Liabilities 13.683.961007.1837.0776.833
Total Non-Current Liabilities 13.683.961007.6837.0776.833
Total Liabilities 17.9597.6991.5070.5789.6947.6457.324
Equity:
Preferred Stock 00007.0777.0776.833
Common Stock 0.0010.0010.0010.001000
Retained Earnings -110.259-54.055-28.726-14.239-8.777-7.786-7.072
Accumulated Other Comprehensive Income/Loss 000-0-7.077-7.077-6.833
Other Total Stockholders Equity 102.50782.37773.2221.7790.2010.1920.107
Total Shareholders Equity -7.75128.32444.4957.541-8.576-7.594-6.966
Total Equity -7.75128.32444.4957.541-8.576-7.594-6.966
Total Liabilities & Shareholders Equity 10.20836.02246.0018.1191.1170.0510.358